The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Targeted Protein Degradation Platform Market Research Report 2025
Synopsis
The global Targeted Protein Degradation Platform market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Targeted Protein Degradation Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Targeted Protein Degradation Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Targeted Protein Degradation Platform in Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Targeted Protein Degradation Platform include Arvinas, Kymera Therapeutics, Plexium, Nurix, Amphista, Cullgen, Hengrui Pharmaceuticals, Hinova Pharmaceuticals and Ranok Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Targeted Protein Degradation Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Protein Degradation Platform.
Report Scope
The Targeted Protein Degradation Platform market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted Protein Degradation Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Protein Degradation Platform companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Arvinas
Kymera Therapeutics
Plexium
Nurix
Amphista
Cullgen
Hengrui Pharmaceuticals
Hinova Pharmaceuticals
Ranok Therapeutics
Segment by Type
PROTAC Platform
Dual-platform (Molecular Glue and PROTAC)
Segment by Application
Cancer
Autoimmune Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Protein Degradation Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Targeted Protein Degradation Platform market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Targeted Protein Degradation Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Targeted Protein Degradation Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Targeted Protein Degradation Platform in Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Targeted Protein Degradation Platform include Arvinas, Kymera Therapeutics, Plexium, Nurix, Amphista, Cullgen, Hengrui Pharmaceuticals, Hinova Pharmaceuticals and Ranok Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Targeted Protein Degradation Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Protein Degradation Platform.
Report Scope
The Targeted Protein Degradation Platform market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted Protein Degradation Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Protein Degradation Platform companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Arvinas
Kymera Therapeutics
Plexium
Nurix
Amphista
Cullgen
Hengrui Pharmaceuticals
Hinova Pharmaceuticals
Ranok Therapeutics
Segment by Type
PROTAC Platform
Dual-platform (Molecular Glue and PROTAC)
Segment by Application
Cancer
Autoimmune Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Protein Degradation Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Protein Degradation Platform Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PROTAC Platform
1.2.3 Dual-platform (Molecular Glue and PROTAC)
1.3 Market by Application
1.3.1 Global Targeted Protein Degradation Platform Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Protein Degradation Platform Market Perspective (2019-2030)
2.2 Targeted Protein Degradation Platform Growth Trends by Region
2.2.1 Global Targeted Protein Degradation Platform Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Targeted Protein Degradation Platform Historic Market Size by Region (2019-2024)
2.2.3 Targeted Protein Degradation Platform Forecasted Market Size by Region (2025-2030)
2.3 Targeted Protein Degradation Platform Market Dynamics
2.3.1 Targeted Protein Degradation Platform Industry Trends
2.3.2 Targeted Protein Degradation Platform Market Drivers
2.3.3 Targeted Protein Degradation Platform Market Challenges
2.3.4 Targeted Protein Degradation Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Protein Degradation Platform Players by Revenue
3.1.1 Global Top Targeted Protein Degradation Platform Players by Revenue (2019-2024)
3.1.2 Global Targeted Protein Degradation Platform Revenue Market Share by Players (2019-2024)
3.2 Global Targeted Protein Degradation Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Targeted Protein Degradation Platform Revenue
3.4 Global Targeted Protein Degradation Platform Market Concentration Ratio
3.4.1 Global Targeted Protein Degradation Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Protein Degradation Platform Revenue in 2023
3.5 Targeted Protein Degradation Platform Key Players Head office and Area Served
3.6 Key Players Targeted Protein Degradation Platform Product Solution and Service
3.7 Date of Enter into Targeted Protein Degradation Platform Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Protein Degradation Platform Breakdown Data by Type
4.1 Global Targeted Protein Degradation Platform Historic Market Size by Type (2019-2024)
4.2 Global Targeted Protein Degradation Platform Forecasted Market Size by Type (2025-2030)
5 Targeted Protein Degradation Platform Breakdown Data by Application
5.1 Global Targeted Protein Degradation Platform Historic Market Size by Application (2019-2024)
5.2 Global Targeted Protein Degradation Platform Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Targeted Protein Degradation Platform Market Size (2019-2030)
6.2 North America Targeted Protein Degradation Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Targeted Protein Degradation Platform Market Size by Country (2019-2024)
6.4 North America Targeted Protein Degradation Platform Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Protein Degradation Platform Market Size (2019-2030)
7.2 Europe Targeted Protein Degradation Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Targeted Protein Degradation Platform Market Size by Country (2019-2024)
7.4 Europe Targeted Protein Degradation Platform Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Protein Degradation Platform Market Size (2019-2030)
8.2 Asia-Pacific Targeted Protein Degradation Platform Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Targeted Protein Degradation Platform Market Size by Region (2019-2024)
8.4 Asia-Pacific Targeted Protein Degradation Platform Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Protein Degradation Platform Market Size (2019-2030)
9.2 Latin America Targeted Protein Degradation Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Targeted Protein Degradation Platform Market Size by Country (2019-2024)
9.4 Latin America Targeted Protein Degradation Platform Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Protein Degradation Platform Market Size (2019-2030)
10.2 Middle East & Africa Targeted Protein Degradation Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Targeted Protein Degradation Platform Market Size by Country (2019-2024)
10.4 Middle East & Africa Targeted Protein Degradation Platform Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arvinas
11.1.1 Arvinas Company Detail
11.1.2 Arvinas Business Overview
11.1.3 Arvinas Targeted Protein Degradation Platform Introduction
11.1.4 Arvinas Revenue in Targeted Protein Degradation Platform Business (2019-2024)
11.1.5 Arvinas Recent Development
11.2 Kymera Therapeutics
11.2.1 Kymera Therapeutics Company Detail
11.2.2 Kymera Therapeutics Business Overview
11.2.3 Kymera Therapeutics Targeted Protein Degradation Platform Introduction
11.2.4 Kymera Therapeutics Revenue in Targeted Protein Degradation Platform Business (2019-2024)
11.2.5 Kymera Therapeutics Recent Development
11.3 Plexium
11.3.1 Plexium Company Detail
11.3.2 Plexium Business Overview
11.3.3 Plexium Targeted Protein Degradation Platform Introduction
11.3.4 Plexium Revenue in Targeted Protein Degradation Platform Business (2019-2024)
11.3.5 Plexium Recent Development
11.4 Nurix
11.4.1 Nurix Company Detail
11.4.2 Nurix Business Overview
11.4.3 Nurix Targeted Protein Degradation Platform Introduction
11.4.4 Nurix Revenue in Targeted Protein Degradation Platform Business (2019-2024)
11.4.5 Nurix Recent Development
11.5 Amphista
11.5.1 Amphista Company Detail
11.5.2 Amphista Business Overview
11.5.3 Amphista Targeted Protein Degradation Platform Introduction
11.5.4 Amphista Revenue in Targeted Protein Degradation Platform Business (2019-2024)
11.5.5 Amphista Recent Development
11.6 Cullgen
11.6.1 Cullgen Company Detail
11.6.2 Cullgen Business Overview
11.6.3 Cullgen Targeted Protein Degradation Platform Introduction
11.6.4 Cullgen Revenue in Targeted Protein Degradation Platform Business (2019-2024)
11.6.5 Cullgen Recent Development
11.7 Hengrui Pharmaceuticals
11.7.1 Hengrui Pharmaceuticals Company Detail
11.7.2 Hengrui Pharmaceuticals Business Overview
11.7.3 Hengrui Pharmaceuticals Targeted Protein Degradation Platform Introduction
11.7.4 Hengrui Pharmaceuticals Revenue in Targeted Protein Degradation Platform Business (2019-2024)
11.7.5 Hengrui Pharmaceuticals Recent Development
11.8 Hinova Pharmaceuticals
11.8.1 Hinova Pharmaceuticals Company Detail
11.8.2 Hinova Pharmaceuticals Business Overview
11.8.3 Hinova Pharmaceuticals Targeted Protein Degradation Platform Introduction
11.8.4 Hinova Pharmaceuticals Revenue in Targeted Protein Degradation Platform Business (2019-2024)
11.8.5 Hinova Pharmaceuticals Recent Development
11.9 Ranok Therapeutics
11.9.1 Ranok Therapeutics Company Detail
11.9.2 Ranok Therapeutics Business Overview
11.9.3 Ranok Therapeutics Targeted Protein Degradation Platform Introduction
11.9.4 Ranok Therapeutics Revenue in Targeted Protein Degradation Platform Business (2019-2024)
11.9.5 Ranok Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Targeted Protein Degradation Platform Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of PROTAC Platform
Table 3. Key Players of Dual-platform (Molecular Glue and PROTAC)
Table 4. Global Targeted Protein Degradation Platform Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Targeted Protein Degradation Platform Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Targeted Protein Degradation Platform Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Targeted Protein Degradation Platform Market Share by Region (2019-2024)
Table 8. Global Targeted Protein Degradation Platform Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Targeted Protein Degradation Platform Market Share by Region (2025-2030)
Table 10. Targeted Protein Degradation Platform Market Trends
Table 11. Targeted Protein Degradation Platform Market Drivers
Table 12. Targeted Protein Degradation Platform Market Challenges
Table 13. Targeted Protein Degradation Platform Market Restraints
Table 14. Global Targeted Protein Degradation Platform Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Targeted Protein Degradation Platform Market Share by Players (2019-2024)
Table 16. Global Top Targeted Protein Degradation Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Protein Degradation Platform as of 2023)
Table 17. Ranking of Global Top Targeted Protein Degradation Platform Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Targeted Protein Degradation Platform Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Targeted Protein Degradation Platform Product Solution and Service
Table 21. Date of Enter into Targeted Protein Degradation Platform Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Targeted Protein Degradation Platform Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Targeted Protein Degradation Platform Revenue Market Share by Type (2019-2024)
Table 25. Global Targeted Protein Degradation Platform Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Targeted Protein Degradation Platform Revenue Market Share by Type (2025-2030)
Table 27. Global Targeted Protein Degradation Platform Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Targeted Protein Degradation Platform Revenue Market Share by Application (2019-2024)
Table 29. Global Targeted Protein Degradation Platform Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Targeted Protein Degradation Platform Revenue Market Share by Application (2025-2030)
Table 31. North America Targeted Protein Degradation Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Targeted Protein Degradation Platform Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Targeted Protein Degradation Platform Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Targeted Protein Degradation Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Targeted Protein Degradation Platform Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Targeted Protein Degradation Platform Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Targeted Protein Degradation Platform Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Targeted Protein Degradation Platform Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Targeted Protein Degradation Platform Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Targeted Protein Degradation Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Targeted Protein Degradation Platform Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Targeted Protein Degradation Platform Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Targeted Protein Degradation Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Targeted Protein Degradation Platform Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Targeted Protein Degradation Platform Market Size by Country (2025-2030) & (US$ Million)
Table 46. Arvinas Company Detail
Table 47. Arvinas Business Overview
Table 48. Arvinas Targeted Protein Degradation Platform Product
Table 49. Arvinas Revenue in Targeted Protein Degradation Platform Business (2019-2024) & (US$ Million)
Table 50. Arvinas Recent Development
Table 51. Kymera Therapeutics Company Detail
Table 52. Kymera Therapeutics Business Overview
Table 53. Kymera Therapeutics Targeted Protein Degradation Platform Product
Table 54. Kymera Therapeutics Revenue in Targeted Protein Degradation Platform Business (2019-2024) & (US$ Million)
Table 55. Kymera Therapeutics Recent Development
Table 56. Plexium Company Detail
Table 57. Plexium Business Overview
Table 58. Plexium Targeted Protein Degradation Platform Product
Table 59. Plexium Revenue in Targeted Protein Degradation Platform Business (2019-2024) & (US$ Million)
Table 60. Plexium Recent Development
Table 61. Nurix Company Detail
Table 62. Nurix Business Overview
Table 63. Nurix Targeted Protein Degradation Platform Product
Table 64. Nurix Revenue in Targeted Protein Degradation Platform Business (2019-2024) & (US$ Million)
Table 65. Nurix Recent Development
Table 66. Amphista Company Detail
Table 67. Amphista Business Overview
Table 68. Amphista Targeted Protein Degradation Platform Product
Table 69. Amphista Revenue in Targeted Protein Degradation Platform Business (2019-2024) & (US$ Million)
Table 70. Amphista Recent Development
Table 71. Cullgen Company Detail
Table 72. Cullgen Business Overview
Table 73. Cullgen Targeted Protein Degradation Platform Product
Table 74. Cullgen Revenue in Targeted Protein Degradation Platform Business (2019-2024) & (US$ Million)
Table 75. Cullgen Recent Development
Table 76. Hengrui Pharmaceuticals Company Detail
Table 77. Hengrui Pharmaceuticals Business Overview
Table 78. Hengrui Pharmaceuticals Targeted Protein Degradation Platform Product
Table 79. Hengrui Pharmaceuticals Revenue in Targeted Protein Degradation Platform Business (2019-2024) & (US$ Million)
Table 80. Hengrui Pharmaceuticals Recent Development
Table 81. Hinova Pharmaceuticals Company Detail
Table 82. Hinova Pharmaceuticals Business Overview
Table 83. Hinova Pharmaceuticals Targeted Protein Degradation Platform Product
Table 84. Hinova Pharmaceuticals Revenue in Targeted Protein Degradation Platform Business (2019-2024) & (US$ Million)
Table 85. Hinova Pharmaceuticals Recent Development
Table 86. Ranok Therapeutics Company Detail
Table 87. Ranok Therapeutics Business Overview
Table 88. Ranok Therapeutics Targeted Protein Degradation Platform Product
Table 89. Ranok Therapeutics Revenue in Targeted Protein Degradation Platform Business (2019-2024) & (US$ Million)
Table 90. Ranok Therapeutics Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted Protein Degradation Platform Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Targeted Protein Degradation Platform Market Share by Type: 2023 VS 2030
Figure 3. PROTAC Platform Features
Figure 4. Dual-platform (Molecular Glue and PROTAC) Features
Figure 5. Global Targeted Protein Degradation Platform Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Targeted Protein Degradation Platform Market Share by Application: 2023 VS 2030
Figure 7. Cancer Case Studies
Figure 8. Autoimmune Diseases Case Studies
Figure 9. Other Case Studies
Figure 10. Targeted Protein Degradation Platform Report Years Considered
Figure 11. Global Targeted Protein Degradation Platform Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Targeted Protein Degradation Platform Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Targeted Protein Degradation Platform Market Share by Region: 2023 VS 2030
Figure 14. Global Targeted Protein Degradation Platform Market Share by Players in 2023
Figure 15. Global Top Targeted Protein Degradation Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Protein Degradation Platform as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Targeted Protein Degradation Platform Revenue in 2023
Figure 17. North America Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Targeted Protein Degradation Platform Market Share by Country (2019-2030)
Figure 19. United States Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Targeted Protein Degradation Platform Market Share by Country (2019-2030)
Figure 23. Germany Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Targeted Protein Degradation Platform Market Share by Region (2019-2030)
Figure 31. China Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Targeted Protein Degradation Platform Market Share by Country (2019-2030)
Figure 39. Mexico Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Targeted Protein Degradation Platform Market Share by Country (2019-2030)
Figure 43. Turkey Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Targeted Protein Degradation Platform Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Arvinas Revenue Growth Rate in Targeted Protein Degradation Platform Business (2019-2024)
Figure 46. Kymera Therapeutics Revenue Growth Rate in Targeted Protein Degradation Platform Business (2019-2024)
Figure 47. Plexium Revenue Growth Rate in Targeted Protein Degradation Platform Business (2019-2024)
Figure 48. Nurix Revenue Growth Rate in Targeted Protein Degradation Platform Business (2019-2024)
Figure 49. Amphista Revenue Growth Rate in Targeted Protein Degradation Platform Business (2019-2024)
Figure 50. Cullgen Revenue Growth Rate in Targeted Protein Degradation Platform Business (2019-2024)
Figure 51. Hengrui Pharmaceuticals Revenue Growth Rate in Targeted Protein Degradation Platform Business (2019-2024)
Figure 52. Hinova Pharmaceuticals Revenue Growth Rate in Targeted Protein Degradation Platform Business (2019-2024)
Figure 53. Ranok Therapeutics Revenue Growth Rate in Targeted Protein Degradation Platform Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
